Claire E. H. Barber

Claire E. H. Barber

Auto-generated profile, based on publicly available information

Claire E. H. Barber

Department of Community Health Sciences Cumming School of Medicine, University of Calgary Calgary Alberta Canada

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
CBClaire E.H. Barber
Claire E.H. Barber
LJLauren Jewett
Lauren Jewett
EBElizabeth M. Badley
Elizabeth M. Badley
DLDiane Lacaille
Diane Lacaille
ACAlfred Cividino
Alfred Cividino
DMDeborah A Marshall
Deborah A Marshall
Objective To characterize the practicing rheumatologist workforce, the Canadian Rheumatology Association (CRA) launched the Stand Up and Be Counted workforce survey in 2015. Methods The survey was distributed electronically to 695 individuals, of whom 519 were expected to be practicing rheumatologists. Demographic and practice information were elicited. We estimated the number of full-time equivalent rheumatologists per 75,000 population from the median proportion of time devoted to clinical practice multiplied by provincial rheumatologist numbers from the Canadian Medical Association. Results The response rate was 68% (355/519) of expected practicing rheumatologists (304 were in adult practice, and 51 pediatric). The median age was 50 years, and one-third planned to retire within the next 5-10 years. The majority (81%) were university-affiliated. Rheumatologists spent a median of 70% of their time in clinical practice, holding 6 half-day clinics weekly, with 10 new consultations and 45 followups seen per week. Work characteristics varied by type of rheumatologist (adult or pediatric) and by practice setting (community- or university-based). We estimated between 0 and 0.8 full-time rheumatologists per 75,000 population in each province. This represents a deficit of 1 to 77 full-time rheumatologists per province/territory to meet the CRA recommendation of 1 rheumatologist per 75,000 population, depending on the province/territory. Conclusion Our results highlight a current shortage of rheumatologists in Canada that may worsen in the next 10 years because one-third of the workforce plans to retire. Efforts to encourage trainees to enter rheumatology and strategies to support retention are critical to address the shortage.

1 July 2011 in Current Opinion in Rheumatology
Verified
Journal Article
Closed access
CBClaire Barber
Claire Barber
WGWayne L Gold
Wayne L Gold
PFPaul R Fortin
Paul R Fortin
Infections are one of the most common causes of morbidity, hospitalization and death in patients with systemic lupus erythematosus (SLE). The aim of the review is to describe an approach to screening and prevention of infections in patients with SLE based on recent evidence. This review summarizes what is known about the incidence and risk factors for infection in SLE as well as the limitations of the current literature. An approach to screening for infections such as tuberculosis and viral hepatitis is described as well as use of prophylactic agents and vaccinations. We recommend screening for infectious comorbidities such as tuberculosis and viral hepatitis at the first clinical encounter in patients with lupus in addition to recommending pneumococcal vaccination and yearly influenza vaccination. There is currently limited evidence to support antibiotic prophylaxis for SLE patients on immunosuppressive agents to prevent penumocystis or to support screening for cytomegalovirus and further study is required. Lastly, timely antibiotic treatment in patients with lupus who are hospitalized with infectious complications is important, as delayed antibiotic treatment may be associated with increased mortality.

21 November 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
DMDeborah A Marshall
Deborah A Marshall
XLXiaoxiao Liu
Xiaoxiao Liu
CBCheryl Barnabe
Cheryl Barnabe
KYKaren Yee
Karen Yee
PFPeter D Faris
Peter D Faris
LLLisa Lix
Lisa Lix
Objectives: The purpose of this study is to estimate the prevalence of comorbidities among people with osteoarthritis (OA) using administrative health data.Design: Retrospective cohort analysis.Setting: All residents in the province of Alberta, Canada registered with the Alberta Health Care Insurance Plan population registry.Participants: 497 362 people with OA as defined by ‘having at least one OA-related hospitalization, or at least two OA-related physician visits or two ambulatory care visits within two years’.Primary outcome measures: We selected eight comorbidities based on literature review, clinical consultation and the availability of validated case definitions to estimate their frequencies at the time of diagnosis of OA. Sex-stratified age-standardised prevalence rates per 1000 population of eight clinically relevant comorbidities were calculated using direct standardisation with 95% CIs. We applied χ2 tests of independence with a Bonferroni correction to compare the percentage of comorbid conditions in each age group.Results: 54.6% (n=2 71 794) of people meeting the OA case definition had at least one of the eight selected comorbidities. Females had a significantly higher rate of comorbidities compared with males (standardised rates ratio=1.26, 95% CI 1.25 to 1.28). Depression, chronic obstructive pulmonary disease (COPD) and hypertension were the most prevalent in both females and males after age-standardisation, with 40% of all cases having any combination of these comorbidities. We observed a significant difference in the percentage of comorbidities among age groups, illustrated by the youngest age group (65 years.Conclusions: Our findings highlight the high frequency of comorbidity in people with OA, with depression having the highest age-standardised prevalence rate. Comorbidities differentially affect females, and vary by age. These factors should inform healthcare programme and delivery.

1 December 2014 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
LWLinda R. Wang
Linda R. Wang
CBClaire E. Barber
Claire E. Barber
AJAndrew S. Johnson
Andrew S. Johnson
CBCheryl Barnabe
Cheryl Barnabe

26 July 2013 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
CBClaire Barber
Claire Barber
DLDiane Lacaille
Diane Lacaille
PFPaul R. Fortin
Paul R. Fortin

1 May 2012 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
CBClaire Barber
Claire Barber
AHAndrew Herzenberg
Andrew Herzenberg
EAEllie Aghdassi
Ellie Aghdassi
JSJiandong Su
Jiandong Su
WLWendy Lou
Wendy Lou
PFPaul R. Fortin
Paul R. Fortin
Summary: Background and objectives: The objective of this study was to determine the clinical significance of renal vascular lesions in lupus nephritis. Design, setting, participants, & measurements: Renal vascular lesions defined as thrombotic microangiopathy, lupus vasculopathy, uncomplicated vascular immune deposits, and arterial sclerosis were evaluated in relation to renal and vascular morbidity and overall mortality. Results: Biopsies from 161 patients revealed thrombotic microangiopathy (13), lupus vasculopathy (5), and arterial sclerosis (93). No renal vascular lesions were found in 24.8% of patients. At the time of biopsy, arterial sclerosis or lupus vasculopathy patients were older (arterial sclerosis=37.9±13.0 and lupus vasculopathy=44.4±8.9 versus controls=33.1±8.9 years, P<0.05), and the mean arterial pressure was higher in all groups compared with controls. Nephritis subtype, activity indices, and proteinuria were similar between groups, estimated GFR was lower in arterial sclerosis (70.5±33.3 versus 84.5±26.6 ml/min per 1.73 m2, P=0.03), and chronicity index (thrombotic microangiopathy=3.5, lupus vasculopathy=4.5, and arterial sclerosis=2.5) was higher in all renal vascular lesions subgroups versus controls (1.0, P<0.05). In 133 patients with similar follow-up, the association between renal vascular lesions and vascular events was significant (Fisher exact test, P=0.002) and remained so after multivariate analysis (exact conditional scores test, P=0.04), where the difference between arterial sclerosis and uncomplicated vascular immune deposits was most noticeable (odds ratio [95% confidence interval]=8.35[0.98, 83.12], P=0.05). The associations between renal vascular lesions, renal outcomes, and death were not significant, likely because of insufficient power. Conclusions: Renal vascular lesions are common in SLE patients with nephritis and may be associated with arterial vascular events.